(firstQuint)Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus.

 The purpose of this study is to assess the reduction in treatment burden during 12 weeks of trelagliptin administration in patients with type 2 diabetes on diet and exercise therapy only.

 Eligible subjects will be randomized to either the study drug (trelagliptin) group or the comparative drug (daily DPP-4 inhibitor) group.

 Treatment burden will be assessed using DTR-QOL questionnaire and DTSQ.

.

 Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus@highlight

The purpose of this study is to assess the reduction in treatment burden during 12 weeks of trelagliptin administration in patients with type 2 diabetes on diet and exercise therapy only.

